The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.
Thanks for your support as we work to rapidly get this testing available to you. You can find the FAQ document here: CTS COVID-19 Questions and Answers
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...